Compare Hims and Hers Health Inc (HIMS) vs Newegg Commerce Inc (NEGG) Price & Performance

Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.

The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.

NEGG trades at $11.69, down 2.66% today, with a bearish technical signal from moving averages but oversold RSI readings. The company shows improving fundamentals with revenue stabilizing around $1.4B and net losses narrowing significantly from -$59M in 2023 to -$4.88M in 2025. Recent earnings beats and strategic partnerships with Western Digital and HPE highlight operational progress, though negative operating cash flow and insider selling present concerns.

The outlook remains mixed with improving profitability trends but significant execution risks. Valuation appears reasonable with P/S of 0.18x, but analyst consensus target of $7.75 suggests 34% downside. Key risks include competitive e-commerce pressures and the need to sustain recent operational improvements amid challenging market conditions.